Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the

B Ola1, S Papaioannou, M A Afnan

  • 1Assisted Conception Unit, Birmingham Women's Hospital, Edgbaston, United Kingdom. bolarinde.ola@bham-women.thenhs.com

Abstract

Related Concept Videos